Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1956 1
1960 1
1961 1
1962 8
1963 18
1964 7
1965 8
1966 12
1967 19
1968 12
1969 5
1970 7
1971 4
1972 18
1973 9
1974 8
1975 9
1976 15
1977 15
1978 17
1979 20
1980 18
1981 17
1982 18
1983 16
1984 31
1985 29
1986 28
1987 35
1988 22
1989 37
1990 38
1991 35
1992 40
1993 64
1994 42
1995 41
1996 58
1997 49
1998 72
1999 86
2000 68
2001 81
2002 87
2003 93
2004 88
2005 114
2006 112
2007 133
2008 131
2009 138
2010 135
2011 154
2012 136
2013 117
2014 118
2015 116
2016 144
2017 170
2018 135
2019 137
2020 147
2021 148
2022 150
2023 76

Text availability

Article attribute

Article type

Publication date

Search Results

3,583 results

Results by year

Filters applied: . Clear all
Page 1
Acute exacerbations of fibrotic interstitial lung diseases.
Suzuki A, Kondoh Y, Brown KK, Johkoh T, Kataoka K, Fukuoka J, Kimura T, Matsuda T, Yokoyama T, Fukihara J, Ando M, Tanaka T, Hashimoto N, Sakamoto K, Hasegawa Y. Suzuki A, et al. Among authors: yokoyama t. Respirology. 2020 May;25(5):525-534. doi: 10.1111/resp.13682. Epub 2019 Aug 19. Respirology. 2020. PMID: 31426125 Free article.
Home-based cardiac rehabilitation using information and communication technology for heart failure patients with frailty.
Nagatomi Y, Ide T, Higuchi T, Nezu T, Fujino T, Tohyama T, Nagata T, Higo T, Hashimoto T, Matsushima S, Shinohara K, Yokoyama T, Eguchi A, Ogusu A, Ikeda M, Ishikawa Y, Yamashita F, Kinugawa S, Tsutsui H. Nagatomi Y, et al. Among authors: yokoyama t. ESC Heart Fail. 2022 Aug;9(4):2407-2418. doi: 10.1002/ehf2.13934. Epub 2022 May 9. ESC Heart Fail. 2022. PMID: 35534907 Free PMC article. Clinical Trial.
Impact of EGFR-TKI Treatment on the Tumor Immune Microenvironment in EGFR Mutation-Positive Non-Small Cell Lung Cancer.
Isomoto K, Haratani K, Hayashi H, Shimizu S, Tomida S, Niwa T, Yokoyama T, Fukuda Y, Chiba Y, Kato R, Tanizaki J, Tanaka K, Takeda M, Ogura T, Ishida T, Ito A, Nakagawa K. Isomoto K, et al. Among authors: yokoyama t. Clin Cancer Res. 2020 Apr 15;26(8):2037-2046. doi: 10.1158/1078-0432.CCR-19-2027. Epub 2020 Jan 14. Clin Cancer Res. 2020. PMID: 31937613
Real-world survey of pneumonitis and its impact on durvalumab consolidation therapy in patients with non-small cell lung cancer who received chemoradiotherapy after durvalumab approval (HOPE-005/CRIMSON).
Saito G, Oya Y, Taniguchi Y, Kawachi H, Daichi F, Matsumoto H, Iwasawa S, Suzuki H, Niitsu T, Miyauchi E, Yokoi T, Yokoyama T, Uenami T, Sakata Y, Arai D, Okada A, Nagata K, Teraoka S, Kokubo M. Saito G, et al. Among authors: yokoyama t. Lung Cancer. 2021 Nov;161:86-93. doi: 10.1016/j.lungcan.2021.08.019. Epub 2021 Sep 5. Lung Cancer. 2021. PMID: 34543942
Chronic Generalized Pruritus.
Yokoyama T. Yokoyama T. N Engl J Med. 2022 Feb 10;386(6):e12. doi: 10.1056/NEJMicm2114503. Epub 2022 Feb 5. N Engl J Med. 2022. PMID: 35119805 No abstract available.
First-line nivolumab + ipilimumab in advanced NSCLC: CheckMate 227 subpopulation analyses in Asian patients.
O'Byrne KJ, Lee KH, Kim SW, Park K, Nishio M, Sakai H, Ohe Y, Fukuhara T, Kang JH, Daga H, Yu CJ, Hotta K, Tanaka H, Takeda M, Yokoyama T, Nathan FE, Lee JS. O'Byrne KJ, et al. Among authors: yokoyama t. ESMO Open. 2022 Feb;7(1):100394. doi: 10.1016/j.esmoop.2022.100394. Epub 2022 Feb 12. ESMO Open. 2022. PMID: 35158207 Free PMC article. Clinical Trial.
A Prospective, Randomized, Open-Label Trial of Early versus Late Favipiravir Therapy in Hospitalized Patients with COVID-19.
Doi Y, Hibino M, Hase R, Yamamoto M, Kasamatsu Y, Hirose M, Mutoh Y, Homma Y, Terada M, Ogawa T, Kashizaki F, Yokoyama T, Koba H, Kasahara H, Yokota K, Kato H, Yoshida J, Kita T, Kato Y, Kamio T, Kodama N, Uchida Y, Ikeda N, Shinoda M, Nakagawa A, Nakatsumi H, Horiguchi T, Iwata M, Matsuyama A, Banno S, Koseki T, Teramachi M, Miyata M, Tajima S, Maeki T, Nakayama E, Taniguchi S, Lim CK, Saijo M, Imai T, Yoshida H, Kabata D, Shintani A, Yuzawa Y, Kondo M. Doi Y, et al. Among authors: yokoyama t. Antimicrob Agents Chemother. 2020 Nov 17;64(12):e01897-20. doi: 10.1128/AAC.01897-20. Print 2020 Nov 17. Antimicrob Agents Chemother. 2020. PMID: 32958718 Free PMC article. Clinical Trial.
Imaging Voltage with Microbial Rhodopsins.
Zhang XM, Yokoyama T, Sakamoto M. Zhang XM, et al. Among authors: yokoyama t. Front Mol Biosci. 2021 Aug 25;8:738829. doi: 10.3389/fmolb.2021.738829. eCollection 2021. Front Mol Biosci. 2021. PMID: 34513932 Free PMC article. Review.
Atezolizumab for Pretreated Non-Small Cell Lung Cancer with Idiopathic Interstitial Pneumonia: Final Analysis of Phase II AMBITIOUS Study.
Ikeda S, Kato T, Kenmotsu H, Ogura T, Sato Y, Hino A, Harada T, Kubota K, Tokito T, Okamoto I, Furuya N, Yokoyama T, Hosokawa S, Iwasawa T, Kasajima R, Miyagi Y, Misumi T, Okamoto H. Ikeda S, et al. Among authors: yokoyama t. Oncologist. 2022 Sep 2;27(9):720-e702. doi: 10.1093/oncolo/oyac118. Oncologist. 2022. PMID: 35759340 Free PMC article. Clinical Trial.
3,583 results